PBHPrestige Consumer Healthcare Inc.
$48.25-24% 1Y
$48.25
$44.7652 weeks$70.21
The financials
Prestige Consumer Healthcare Inc. by the numbers
Prestige Consumer Healthcare Inc. (PBH) reported revenue of $266M in Q1 2027 (quarter ended Jun 30, 2026), up 6.5% from the same quarter a year earlier. That came with a gross margin of 51% and net income of $29M (11% of revenue). For the full year FY2026, revenue was $1.09B (−4.3% year on year) and net income $190M. Its largest product in Q1 2027 was Womens Health at $47M, 20.4% of the disclosed total, just ahead of Gastrointestinal at 20.4%. The next results filing is expected around Nov 5, 2026, the same week as a year ago.
| Income statement | Q1 2027 | Q1 2026 | Change |
|---|---|---|---|
| Revenue | $266M | $250M | +6.5% |
| Gross profit | $136M | $140M | −3.0% |
| Operating income | $53M | $72M | −27% |
| Net income | $29M | $47M | −39% |
| Diluted EPS | $0.61 | $0.95 | −36% |
| Product | Revenue | Share |
|---|---|---|
| Womens Health | $47M | 20% |
| Gastrointestinal | $47M | 20% |
| Dermatologicals | $31M | 13% |
| Eye And Ear Care | $28M | 12% |
| Pain Relief | $26M | 11% |
| Oral Care | $18M | 8.0% |
| Cough Cold And Allergy | $16M | 6.7% |
| Wellness Sleep Other | $13M | 5.4% |
| Product And Service Other | $5.4M | 2.3% |
Business segments
Revenue split by product segment, from SEC XBRL filings.
Latest period: Jun 2026Total $231.6M (-3.3%)
Product And Service Other grew +2033% year on yearWomens Health -5.1% year on year
Segment Latestquarter on quarteryear on year
- Womens Health$47.2M$47.2Mquarter on quarter -11%year on year -5.1%-11%-5.1%
- Gastrointestinal$47.1M$47.1Mquarter on quarter +4.9%year on year +7.9%+4.9%+7.9%
- Dermatologicals$30.6M$30.6Mquarter on quarter +7.8%year on year +9.9%+7.8%+9.9%
- Eye And Ear Care$28.3M$28.3Mquarter on quarter -16%year on year +2.0%-16%+2.0%
- Pain Relief$26.2M$26.2Mquarter on quarter n/ayear on year -3.8%n/a-3.8%
- Oral Care$18.5M$18.5Mquarter on quarter -24%year on year +1.7%-24%+1.7%
- Cough Cold And Allergy$15.6M$15.6Mquarter on quarter n/ayear on year +17%n/a+17%
- Wellness Sleep Other$12.6M$12.6Mquarter on quarter n/ayear on year +166%n/a+166%
- Product And Service Other$5.4M$5.4Mquarter on quarter +82%year on year +2033%+82%+2033%
On our screens:Cheap stocks by free cash flow yield
Drug Manufacturers, Specialty & Generic
Ranks #11 of 41 by RyuScore